![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Cooper D S. Hyperthyroidism. Lancet 2003; 362: 459–468
- Foulds N, Walpole I, Elmslie F, et al. Carbimazole embryopathy: an emerging phenotype. American Journal of Medical Genetics 2005; 132A: 130–135
- Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocrine Reviews 1997; 18: 404–433
- Karabinas C D, Tolis G J. Thyroid disorders and pregnancy. Journal of Obstetrics and Gynaecology 1998; 18: 509–515
- Kriplani A, Buckshee K, Bhargava V L, et al. Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy. European Journal of Obstetrics, Gynecology and Reproductive Biology 1994; 54: 159–163
- Kroll H, Sun Q H, Santoso S. Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a target glycoprotein in drug-induced thrombocytopenia. Blood 2000; 96: 1409–1414
- Marazuela M, Sanchez de Paco G, Jimenez I, et al. Acute pancreatitis, hepatic cholestasis, and erythema nodosum induced by carbimazole treatment for Graves' disease. Endocrine Journal 2002; 49: 315–318
- Millar L K, Wing D A, Leung A S, et al. Low birth weight and pre-eclampsia in pregnancies complicated by hyperthyroidism. Obstetrics and Gynecology 1994; 84: 946–949
- Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clinical Endocrinology (Oxf) 1984; 20: 695–700
- Vanderpump M PJ, Ahlquist J AO, Franklyn J A, et al. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. British Medical Journal 1996; 313: 539–544